Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VIR · as of Jun 9, 2026
Key Statistics
Explore Vir Biotechnology, Inc. Data
vir stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The VIR analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $21.14, representing +150.18% upside from the current price of $8.45.
Competitors & Peers
vir competitorsVIR
DAWN
DNA
GERN
IOVA
KURAStock Performance
Full HistoryAbout Vir Biotechnology, Inc.
Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases.…
what is vir biotechnology, inc. · vir stock overview · vir biotechnology, inc. company profile · who is vir biotechnology, inc. ceo · vir NASDAQ · vir biotechnology, inc. headquarters · vir biotechnology, inc. business segments
About Stock Overview & Key Data
Vir Biotechnology, Inc. (VIR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2019. As of the latest trading session, VIR stock price is $8.45, with a market capitalization of $1.4B. The stock has returned +56.97% over the past 12 months and +41.35% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Vir Biotechnology, Inc. stock is Buy, with an average 12-month price target of $21.14. In fiscal year 2025, Vir Biotechnology, Inc. reported revenue of $68.6M and net income of -$438.0M. For detailed data — including Vir Biotechnology, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vir Biotechnology, Inc. (VIR) stock price is $8.45. The stock is traded on NASDAQ under the ticker symbol VIR. The 52-week range is $4.16 – $11.66.